Browsing bySubjectImmune checkpoint inhibitor

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
가 나 다 라 마 바 사 아 자 차 카 타 파 하
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 5 of 5

Issue DateTitleAuthor(s)Type
2021Analysis of risk factors for hepatotoxicity induced by immune checkpoint inhibitors곽혜선Article
2024Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy임선아Review
2026Predictive and Prognostic Value of p16 in Head and Neck Squamous Cell Carcinoma Patients Treated with Molecular Targeted Agents or Immune Checkpoint Inhibitors: Subgroup Analysis of the TRIUMPH Study이경은Article
2020Real-world experience of pembrolizumab monotherapy in patients with recurrent or persistent cervical cancer: A korean multi-center retrospective study (KGOG1041)김미경Article
2022The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS배승진Article

BROWSE